233 related articles for article (PubMed ID: 30898575)
21. Efficient gene transfer into primary human CD8+ T lymphocytes by MuLV-10A1 retrovirus pseudotype.
Uckert W; Becker C; Gladow M; Klein D; Kammertoens T; Pedersen L; Blankenstein T
Hum Gene Ther; 2000 May; 11(7):1005-14. PubMed ID: 10811229
[TBL] [Abstract][Full Text] [Related]
22. Retrovirus packaging cells based on 10A1 murine leukemia virus for production of vectors that use multiple receptors for cell entry.
Miller AD; Chen F
J Virol; 1996 Aug; 70(8):5564-71. PubMed ID: 8764070
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of retroviral vectors based on the gibbon ape leukemia virus.
Eglitis MA; Schneiderman RD; Rice PM; Eiden MV
Gene Ther; 1995 Sep; 2(7):486-92. PubMed ID: 7584127
[TBL] [Abstract][Full Text] [Related]
24. Adenovirus-retrovirus hybrid vectors achieve highly enhanced tumor transduction and antitumor efficacy in vivo.
Kubo S; Haga K; Tamamoto A; Palmer DJ; Ng P; Okamura H; Kasahara N
Mol Ther; 2011 Jan; 19(1):76-82. PubMed ID: 20808291
[TBL] [Abstract][Full Text] [Related]
25. Tissue-specific transcriptional targeting of a replication-competent retroviral vector.
Logg CR; Logg A; Matusik RJ; Bochner BH; Kasahara N
J Virol; 2002 Dec; 76(24):12783-91. PubMed ID: 12438603
[TBL] [Abstract][Full Text] [Related]
26. Gene transfer into mammalian cells by a Rous sarcoma virus-based retroviral vector with the host range of the amphotropic murine leukemia virus.
Barsov EV; Hughes SH
J Virol; 1996 Jun; 70(6):3922-9. PubMed ID: 8648729
[TBL] [Abstract][Full Text] [Related]
27. Replicating retroviral vectors for oncolytic virotherapy of experimental hepatocellular carcinoma.
Lu YC; Chen YJ; Yu YR; Lai YH; Cheng JC; Li YF; Shen CH; Tai CK
Oncol Rep; 2012 Jul; 28(1):21-6. PubMed ID: 22552490
[TBL] [Abstract][Full Text] [Related]
28. Variable regions A and B in the envelope glycoproteins of feline leukemia virus subgroup B and amphotropic murine leukemia virus interact with discrete receptor domains.
Tailor CS; Kabat D
J Virol; 1997 Dec; 71(12):9383-91. PubMed ID: 9371598
[TBL] [Abstract][Full Text] [Related]
29. Characterization of recombinant nonecotropic murine leukemia viruses from the wild mouse species Mus spretus.
Jung YT; Wu T; Kozak CA
J Virol; 2003 Dec; 77(23):12773-81. PubMed ID: 14610199
[TBL] [Abstract][Full Text] [Related]
30. Cytoplasmic R-peptide of murine leukemia virus envelope protein negatively regulates its interaction with the cell surface receptor.
Kubo Y; Izumida M; Togawa K; Zhang F; Hayashi H
Virology; 2019 Jun; 532():82-87. PubMed ID: 31035110
[TBL] [Abstract][Full Text] [Related]
31. A murine leukemia virus (MuLV) long terminal repeat derived from rhesus macaques in the context of a lentivirus vector and MuLV gag sequence results in high-level gene expression in human T lymphocytes.
Kung SK; An DS; Chen IS
J Virol; 2000 Apr; 74(8):3668-81. PubMed ID: 10729143
[TBL] [Abstract][Full Text] [Related]
32. Improved gene transfer into human lymphocytes using retroviruses with the gibbon ape leukemia virus envelope.
Lam JS; Reeves ME; Cowherd R; Rosenberg SA; Hwu P
Hum Gene Ther; 1996 Aug; 7(12):1415-22. PubMed ID: 8844200
[TBL] [Abstract][Full Text] [Related]
33. Adaptive evolution of a tagged chimeric gammaretrovirus: identification of novel cis-acting elements that modulate splicing.
Logg CR; Baranick BT; Lemp NA; Kasahara N
J Mol Biol; 2007 Jun; 369(5):1214-29. PubMed ID: 17498744
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of infectious murine leukemia virus production by Fv-4 env gene products exerting dominant negative effect on viral envelope glycoprotein.
Takeda A; Matano T
Microbes Infect; 2007; 9(14-15):1590-6. PubMed ID: 18023391
[TBL] [Abstract][Full Text] [Related]
35. Beyond oncolytic virotherapy: replication-competent retrovirus vectors for selective and stable transduction of tumors.
Dalba C; Klatzmann D; Logg CR; Kasahara N
Curr Gene Ther; 2005 Dec; 5(6):655-67. PubMed ID: 16457654
[TBL] [Abstract][Full Text] [Related]
36. Transplantation of transduced nonhuman primate CD34+ cells using a gibbon ape leukemia virus vector: restricted expression of the gibbon ape leukemia virus receptor to a subset of CD34+ cells.
Bunnell BA; Kluge KA; Lee-Lin SQ; Byrne ER; Orlic D; Metzger ME; Agricola BA; Wersto RP; Bodine DM; Morgan RA; Donahue RE
Gene Ther; 1999 Jan; 6(1):48-56. PubMed ID: 10341875
[TBL] [Abstract][Full Text] [Related]
37. Generation of novel syncytium-inducing and host range variants of ecotropic moloney murine leukemia virus in Mus spicilegus.
Jung YT; Kozak CA
J Virol; 2003 May; 77(9):5065-72. PubMed ID: 12692209
[TBL] [Abstract][Full Text] [Related]
38. Entry of amphotropic and 10A1 pseudotyped murine retroviruses is restricted in hematopoietic stem cell lines.
von Laer D; Thomsen S; Vogt B; Donath M; Kruppa J; Rein A; Ostertag W; Stocking C
J Virol; 1998 Feb; 72(2):1424-30. PubMed ID: 9445044
[TBL] [Abstract][Full Text] [Related]
39. Enhancer-deficient amphotropic murine leukemia virus and recombinants with heterologous transcription elements can be efficiently amplified and detected in Mus dunni fibroblasts.
Reuss FU; Berdel B; Heber R; Ploss M
Gene Ther; 2002 Sep; 9(17):1183-8. PubMed ID: 12170382
[TBL] [Abstract][Full Text] [Related]
40. Fusion-defective gibbon ape leukemia virus vectors can be rescued by homologous but not heterologous soluble envelope proteins.
Farrell KB; Ting YT; Eiden MV
J Virol; 2002 May; 76(9):4267-74. PubMed ID: 11932392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
